Alpha 2.0
Login Register
» Articles » PMID: 16932244

Graves' Hyperthyroidism: How Long Should Antithyroid Drug Therapy Be Continued to Achieve Remission?

Overview
Journal Nat Clin Pract Endocrinol Metab
Specialty Endocrinology
Date 2006 Aug 26
PMID 16932244
Citations 8
Authors
Anthony P Weetman
Affiliations
Soon will be listed here.
Citing Articles

"Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.

Vigone M, Peroni E, Di Frenna M, Mora S, Barera G, Weber G J Endocrinol Invest. 2019; 43(5):595-600.

PMID: 31713721 DOI: 10.1007/s40618-019-01144-0.

[Difficulties in managing Graves' disease in children: about a case].

Elouarradi N, El Mghari G, El Ansari N Pan Afr Med J. 2018; 30:183.

PMID: 30455812 PMC: 6235467. DOI: 10.11604/pamj.2018.30.183.15325.

Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.

Minamitani K, Sato H, Ohye H, Harada S, Arisaka O Clin Pediatr Endocrinol. 2017; 26(2):29-62.

PMID: 28458457 PMC: 5402306. DOI: 10.1297/cpe.26.29.

Controversies in the management of Graves' disease in children.

Rivkees S J Endocrinol Invest. 2016; 39(11):1247-1257.

PMID: 27153850 DOI: 10.1007/s40618-016-0477-x.

Pediatric Graves' disease: management in the post-propylthiouracil Era.

Rivkees S Int J Pediatr Endocrinol. 2014; 2014(1):10.

PMID: 25089127 PMC: 4118280. DOI: 10.1186/1687-9856-2014-10.